Preclinical CRO
We are thought leaders in pharmacology and imaging.
With expertise in multiple therapeutic areas, our industry knowledgeable scientists provide seamless support for your R&D effort.
PDX models
Our process begins with the right model selection.
With our deep pharmacology and models expertise, your studies are implemented correctly from the beginning.
Molecular Imaging Preclinical Oncology
We stand beside you and your science.
With personalized attention, flexibility and responsiveness, we become an extension of your team.
Preclinical Imaging
We set the standard for industry relevant protocols.
We offer a broad array of efficient, validated pharmacology and imaging protocols to meet your needs.

Molecular Imaging, Inc. (MII) is a premier preclinical oncology CRO (Contract Research Organization) with outstanding expertise and one of the broadest and most mature ranges of models and services in the industry. We offer an unparalleled array of cutting-edge technologies to meet the demands of the rapidly changing field, and run a world class immuno-oncology services program. MII focuses on quality, flexibility, and speed to provide clients with unique decision-enabling data to advance their preclinical and translational programs.



July 19, 2016 - Boston, MA




Preclinical Contract Research Organisation specializing in Multi-Modality Imaging studies across a wide range of Therapeutic Areas that enhance the effectiveness and efficiency of R&D decision making efforts for new drugs, biologics, devices and diagnostics.